学术探索
学术期刊
学术作者
新闻热点
数据分析
智能评审
DECREASED PHENYTOIN LEVEL AFTER CARBOPLATIN TREATMENT
被引:20
作者
:
DOFFERHOFF, ASM
论文数:
0
引用数:
0
h-index:
0
DOFFERHOFF, ASM
BERENDSEN, HH
论文数:
0
引用数:
0
h-index:
0
BERENDSEN, HH
VANDERNAALT, J
论文数:
0
引用数:
0
h-index:
0
VANDERNAALT, J
HAAXMAREICHE, H
论文数:
0
引用数:
0
h-index:
0
HAAXMAREICHE, H
SMIT, EF
论文数:
0
引用数:
0
h-index:
0
SMIT, EF
POSTMUS, PE
论文数:
0
引用数:
0
h-index:
0
POSTMUS, PE
机构
:
来源
:
AMERICAN JOURNAL OF MEDICINE
|
1990年
/ 89卷
/ 02期
关键词
:
D O I
:
10.1016/0002-9343(90)90308-Z
中图分类号
:
R5 [内科学];
学科分类号
:
1002
[临床医学]
;
100201
[内科学]
;
摘要
:
[No abstract available]
引用
收藏
页码:247 / 248
页数:2
相关论文
共 5 条
[1]
GRAHAMESMITH DG, 1985, OXFORD TXB CLIN PHAR, P158
[2]
CARBOPLATIN AND ETOPOSIDE PHARMACOKINETICS IN PATIENTS WITH TESTICULAR TERATOMA
[J].
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
NEWELL, DR
;
EELES, RA
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
EELES, RA
;
GUMBRELL, LA
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
GUMBRELL, LA
;
BOXALL, FE
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
BOXALL, FE
;
HORWICH, A
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
HORWICH, A
;
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
CALVERT, AH
.
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1989,
23
(06)
:367
-372
[3]
POSTMUS PE, IN PRESS SEMIN ONCOL
[4]
ANTIPYRINE METABOLISM IN PATIENTS WITH DISSEMINATED TESTICULAR CANCER AND THE INFLUENCE OF CYTOSTATIC TREATMENT
[J].
TEUNISSEN, MWE
论文数:
0
引用数:
0
h-index:
0
机构:
LEIDEN STATE UNIV,SUBFAC PHARM,DEPT PHARMACOL,2300 RA LEIDEN,NETHERLANDS
TEUNISSEN, MWE
;
WILLEMSE, PHB
论文数:
0
引用数:
0
h-index:
0
机构:
LEIDEN STATE UNIV,SUBFAC PHARM,DEPT PHARMACOL,2300 RA LEIDEN,NETHERLANDS
WILLEMSE, PHB
;
SLEIJFER, DT
论文数:
0
引用数:
0
h-index:
0
机构:
LEIDEN STATE UNIV,SUBFAC PHARM,DEPT PHARMACOL,2300 RA LEIDEN,NETHERLANDS
SLEIJFER, DT
;
SLUITER, WJ
论文数:
0
引用数:
0
h-index:
0
机构:
LEIDEN STATE UNIV,SUBFAC PHARM,DEPT PHARMACOL,2300 RA LEIDEN,NETHERLANDS
SLUITER, WJ
;
BREIMER, DD
论文数:
0
引用数:
0
h-index:
0
机构:
LEIDEN STATE UNIV,SUBFAC PHARM,DEPT PHARMACOL,2300 RA LEIDEN,NETHERLANDS
BREIMER, DD
.
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1984,
13
(03)
:181
-185
[5]
VANECHO DA, 1989, SEMIN ONCOL, V16, P1
←
1
→
共 5 条
[1]
GRAHAMESMITH DG, 1985, OXFORD TXB CLIN PHAR, P158
[2]
CARBOPLATIN AND ETOPOSIDE PHARMACOKINETICS IN PATIENTS WITH TESTICULAR TERATOMA
[J].
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
NEWELL, DR
;
EELES, RA
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
EELES, RA
;
GUMBRELL, LA
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
GUMBRELL, LA
;
BOXALL, FE
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
BOXALL, FE
;
HORWICH, A
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
HORWICH, A
;
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
ROYAL MARSDEN HOSP,RADIOTHERAPY SECT,SUTTON,SURREY,ENGLAND
CALVERT, AH
.
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1989,
23
(06)
:367
-372
[3]
POSTMUS PE, IN PRESS SEMIN ONCOL
[4]
ANTIPYRINE METABOLISM IN PATIENTS WITH DISSEMINATED TESTICULAR CANCER AND THE INFLUENCE OF CYTOSTATIC TREATMENT
[J].
TEUNISSEN, MWE
论文数:
0
引用数:
0
h-index:
0
机构:
LEIDEN STATE UNIV,SUBFAC PHARM,DEPT PHARMACOL,2300 RA LEIDEN,NETHERLANDS
TEUNISSEN, MWE
;
WILLEMSE, PHB
论文数:
0
引用数:
0
h-index:
0
机构:
LEIDEN STATE UNIV,SUBFAC PHARM,DEPT PHARMACOL,2300 RA LEIDEN,NETHERLANDS
WILLEMSE, PHB
;
SLEIJFER, DT
论文数:
0
引用数:
0
h-index:
0
机构:
LEIDEN STATE UNIV,SUBFAC PHARM,DEPT PHARMACOL,2300 RA LEIDEN,NETHERLANDS
SLEIJFER, DT
;
SLUITER, WJ
论文数:
0
引用数:
0
h-index:
0
机构:
LEIDEN STATE UNIV,SUBFAC PHARM,DEPT PHARMACOL,2300 RA LEIDEN,NETHERLANDS
SLUITER, WJ
;
BREIMER, DD
论文数:
0
引用数:
0
h-index:
0
机构:
LEIDEN STATE UNIV,SUBFAC PHARM,DEPT PHARMACOL,2300 RA LEIDEN,NETHERLANDS
BREIMER, DD
.
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1984,
13
(03)
:181
-185
[5]
VANECHO DA, 1989, SEMIN ONCOL, V16, P1
←
1
→